Continuous Glucose Monitoring (CGM) for women with Gestational Diabetes Mellitus (GDM) study: pilot
Not Applicable
Recruiting
- Conditions
- Gestational diabetesMetabolic and Endocrine - DiabetesReproductive Health and Childbirth - Fetal medicine and complications of pregnancy
- Registration Number
- ACTRN12618000050257
- Lead Sponsor
- Mercy Health (Werribee Mercy Hospital)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Pregnant
-GDM diagnosed at 24-28 week gestation based on routine 75g-OGTT
-Willing to wear CGM
-Willing to perform 4 self-monitored blood glucose (SMBG) readings each day
Exclusion Criteria
-Pre-existing diabetes (type 1 or type 2 diabetes)
-Early GDM diagnosed prior to 24 weeks gestation
-Multiple pregnancy
-Known major congenital abnormality for current pregnancy
-Maternal age <18 years
-Allergic reaction to adhesive dressing
-Other major maternal medical co-morbidities requiring intensive clinical follow-up
-Already on treatment (metformin or insulin) for GDM management
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method